NCT03519412 2026-03-03ARETHUSAIFOM ETS - The AIRC Institute of Molecular OncologyPhase 2 Completed107 enrolled 14 charts
NCT06004245 2026-02-17A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid TumorsVividion Therapeutics, Inc.Phase 1 Recruiting295 enrolled
NCT03228667 2026-01-14QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsImmunityBio, Inc.Phase 2 Active not recruiting40 enrolled